Identification of new classes among acute myelogenous leukaemias with normal karyotype using gene expression profiling

Oncogene

Volumn 23, Issue 58, 2004, Pages 9381-9391

  Vey, Norbert ^a   Mozziconacci, Marie Joëlle ^a   Groulet Martinec, Agnès ^b   Debono, Stéphane ^b   Finetti, Pascal ^a   Carbuccia, Nadine ^a   Beillard, Emmanuel ^c   Devilard, Elizabeth ^a   Arnoulet, Christine ^a   Coso, Diane ^a   Sainty, Danielle ^a   Xerri, Luc ^a,d   Stoppa, Anne Marie ^a   Lafage Pochitaloff, Marina ^a,d   Nguyen, Catherine ^e   Houlgatte, Rémi ^e   Blaise, Didier ^a   Maraninchi, Dominique ^a,d   Birg, Françoise ^a   Birnbaum, Daniel ^a,f   Bertucci, François ^a,d   more..

^a INSTITUT PAOLI CALMETTES   (France)

^b Ipsogen SA   (France)

^c ERT MEIDIA   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

^e Parc Scientifique de Luminy   (France)

^f INSERM   (France)

Author keywords

Acute myelogenous leukaemia; Chemotherapy; DNA microarrays; FLT3; Gene expression; Normal karyotype

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CHROMOSOME 7Q; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CLUSTER ANALYSIS; CONTROLLED STUDY; CYTOGENETICS; DNA MICROARRAY; DRUG RESISTANCE; EXPRESSED SEQUENCE TAG; FLT3 GENE; GENE; GENE DUPLICATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION SIGNATURE; GENE EXPRESSION SYSTEM; GENE IDENTIFICATION; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; KARYOTYPE; MAPK1 GENE; MLL GENE; MTX2 GENE; NUCLEOTIDE SEQUENCE; OUTCOMES RESEARCH; PHYLOGENETIC TREE; PRIORITY JOURNAL; PRKAB2 GENE; PROGNOSIS; SLC35A2 GENE; STATISTICAL SIGNIFICANCE; TOP2B GENE; TRANSCRIPTION REGULATION; TRISOMY 8;

DNA-BINDING PROTEINS; FMS-LIKE TYROSINE KINASE 3; GENE DUPLICATION; GENE EXPRESSION PROFILING; HUMANS; KARYOTYPING; LEUKEMIA, MYELOCYTIC, ACUTE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENES; RECEPTOR PROTEIN-TYROSINE KINASES; TRANSCRIPTION FACTORS;

EID: 19944427098     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207910     Document Type: Article

References (39)

1. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson Jr J, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever M, Byrd J, Botstein D, Brown PO and Staudt LM. (2000). Nature, 403, 503-511.
2. Bachrati CZ and Hickson ID. (2003). Biochem. J., 374, 577-606.
3. Bertucci F, Houlgatte R, Benziane A, Granjeaud S, Adelaide J, Tagett R, Loriod B, Jacquemier J, Viens P, Jordan B, Birnbaum D and Nguyen C. (2000). Hum. Mol. Genet., 9, 2981-2991.
4. Bertucci F, Houlgatte R, Nguyen C, Viens P, Jordan BR and Birnbaum D. (2001). Lancet Oncol., 2, 674-682.
5. Bertucci F, Nasser V, Granjeaud S, Eisinger F, Adelaide J, Tagett R, Loriod B, Giaconia A, Benziane A, Devilard E, Jacquemier J, Viens P, Nguyen C, Birnbaum D and Houlgatte R. (2002). Hum. Mol. Genet., 11, 863-872.
6. Bonilla E and del Mazo J. (2003). Biochem. Pharmacol., 65, 1701-1707.
7. Bullinger L, Dohner K, Bair E, Frohling S, Schlenk RF, Tibshirani R, Dohner H and Pollack JR. (2004). N. Engl. J. Med., 350, 1605-1616.
8. Debernardi S, Lillington DM, Chaplin T, Tomlinson S, Amess J, Rohatiner A, Lister TA and Young BD. (2003). Genes Chromosomes Cancer, 37, 149-158.
9. Dingemans AM, Witlox MA, Stallaert RA, van der Valk P, Postmus PE and Giaccone G. (1999). Clin. Cancer Res., 5, 2048-2058.
10. Downing JR and Shannon KM. (2002). Cancer Cell, 2, 437-445.
11. Goasguen JE, Matsuo T, Cox C and Bennett JM. (1992). Leukemia, 6, 520-525.
12. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD and Lander ES. (1999). Science, 286, 531-537.
13. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, Rees J, Hann I, Stevens R, Burnett A and Goldstone A. (1998). Blood, 92, 2322-2333.
14. Haferlach T, Kohlmann A, Kern W, Hiddemann W, Schnittger S and Schoch C. (2003a). Semin. Hematol., 40, 281-295.
15. Haferlach T, Schoch C, Loffler H, Gassmann W, Kern W, Schnittger S, Fonatsch C, Ludwig WD, Wuchter C, Schlegelberger B, Staib P, Reichle A, Kubica U, Eimermacher H, Balleisen L, Gruneisen A, Haase D, Aul C, Karow J, Lengfelder E, Wormann B, Heinecke A, Sauerland MC, Buchner T and Hiddemann W. (2003b). J. Clin. Oncol., 21, 256-265.
16. Iyer L, King CD, Whitington PF, Green MD, Roy SK, Tephly TR, Coffman BL and Ratain MJ. (1998). J. Clin. Invest., 101, 847-854.
17. Jaffrey SR and Snyder SH. (1996). Science, 274, 774-777.
18. Kato K, Ogura T, Kishimoto A, Minegishi Y, Nakajima N, Miyazaki M and Esumi H. (2002). Oncogene, 21, 6082-6090.
19. Kaufmann SH, Gore SD, Miller CB, Jones RJ, Zwelling LA, Schneider E, Burke PJ and Karp JE. (1998). Leukemia Lymphoma, 29, 217-237.
20. Kohlmann A, Schoch C, Schnittger S, Dugas M, Hiddemann W, Kern W and Haferlach T. (2003). Genes Chromosomes Cancer, 37, 396-405.
21. Kottaridis PD, Gale RE, Frew ME, Harrison G, Langabeer SE, Belton AA, Walker H, Wheatley K, Bowen DT, Burnett AK, Goldstone AH and Linch DC. (2001). Blood, 98, 1752-1759.
22. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F and Berger R. (1991). Blood, 77, 1080-1086.
23. Marcucci G, Caligiuri MA and Bloomfield CD. (2000). Cancer Invest., 18, 768-780.
24. Noguera NI, Breccia M, Divona M, Diverio D, Costa V, De Sands S, Avvisati G, Pinazzi MB, Petti MC, Mandelli F and Lo Coco F. (2002). Leukemia, 16, 2185-2189.
25. Okutsu J, Tsunoda T, Kaneta Y, Katagiri T, Kitahara O, Zembutsu H, Yanagawa R, Miyawaki S, Kuriyama K, Kubota N, Kimura Y, Kubo K, Yagasaki F, Higa T, Taguchi H, Tobita T, Akiyama H, Takeshita A, Wang YH, Motoji T, Ohno R and Nakamura Y. (2002). Mol. Cancer Ther., 1, 1035-1042.
26. Pinto A, Zagonel V and Ferrara F. (2001). Crit. Rev. Oncol.l Hematol., 39, 275-287.
27. Poirel H, Rack K, Delabesse E, Radford-Weiss I, Troussard X, Debert C, Leboeuf D, Bastard C, Picard F, Veil-Buzyn A, Flandrin G, Bernard O and Macintyre E. (1996). Blood, 87, 2496-2505.
28. Reid HM and Kinsella BT. (2003). J. Biol. Chem., 278, 51190-51202.
29. Reiffers J, Huguet F, Stoppa AM, Molina L, Marit G, Attal M, Gastaut JA, Michallet M, Lepeu G, Broustet A, Pris J, Maraninchi D, Hollard D, Faberes C, Mercier M, Hurteloup P, Danel P, Tellier Z and Berthaud P. (1996a). Leukemia, 10, 389-395.
30. Reiffers J, Stoppa AM, Attal M, Michallet M, Marit G, Blaise D, Huguet F, Corront B, Cony-Makhoul P, Gastaut JA, Laurent G, Molina L, Broustet A, Maraninchi D, Pris J, Hollard D and Faberes C. (1996b). Leukemia, 10, 1874-1882.
31. Sabatti C, Karsten SL and Geschwind DH. (2002). Math. Biosci., 176, 17-34.
32. Schoch C, Kohlmann A, Schnittger S, Brors B, Dugas M, Mergenthaler S, Kern W, Hiddemann W, Eils R and Haferlach T. (2002). Proc. Natl. Acad. Sci. USA, 99, 10008-10013.
33. Tanaka K, Roberts MH, Yamamoto N, Sugiura H, Uehara M, Mao XQ, Shirakawa T and Hopkin JM. (2002). Biochem. Biophys. Res. Commun., 292, 776-780.
34. Theillet C, Adelaide J, Louason G, Bonnet-Dorion F, Jacquemier J, Adnane J, Longy M, Katsaros D, Sismondi P, Gaudray P and Birnbaum D. (1993). Genes Chromosomes Cancer, 7, 219-226.
35. Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, van Waalwijk van Doorn-Khosrovani SB, Boer JM, Beverloo HB, Moorhouse MJ, van der Spek PJ, Lowenberg B and Delwel R. (2004). N. Engl. J. Med., 350, 1617-1628.
36. Virtaneva K, Wright FA, Tanner SM, Yuan B, Lemon WJ, Caligiuri MA, Bloomfield CD, de La Chapelle A and Krahe R. (2001). Proc. Natl. Acad. Sci. USA, 98, 1124-1129.
37. Wallqvist A, Rabow AA, Shoemaker RH, Sausville EA and Covell DG. (2003). Bioinformatics, 19, 2212-2224.
38. Yagi T, Morimoto A, Eguchi M, Hibi S, Sako M, Ishii E, Mizutani S, Imashuku S, Ohki M and Ichikawa H. (2003). Blood, 102, 1849-1856.
39. Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R, Behm FG, Raimondi SC, Relling MV, Patel A, Cheng C, Campana D, Wilkins D, Zhou X, Li J, Liu H, Pui CH, Evans WE, Naeve C, Wong L and Downing JR. (2002). Cancer Cell, 1, 133-143.